The DOI matches its Crossref record; 206 of the 206 references it cites were found in a registry or an index.
Drug delivery strategies in the therapy of inflammatory bowel disease
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Recent advances with liposomes as pharmaceutical carriers
Torchilin, V. P. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1632 · Cited by 5,282
Liposomal drug delivery systems: From concept to clinical applications
Allen, T. M., & Cullis, P. R. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.037 · Cited by 4,839
Unravelling the pathogenesis of inflammatory bowel disease
Xavier, R. J., & Podolsky, D. K. (2007) · Nature · doi:10.1038/nature06005 · Cited by 4,364
Loftus, E. V. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.01.063 · Cited by 3,117
Genetics and pathogenesis of inflammatory bowel disease
Khor, B., Gardet, A., & Xavier, R. J. (2011) · Nature · doi:10.1038/nature10209 · Cited by 2,614
Jain, R. A. (2000) · Biomaterials · doi:10.1016/s0142-9612(00)00115-0 · Cited by 2,214
Microemulsion-based media as novel drug delivery systems
Lawrence, M. J., & Rees, G. D. (2000) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00103-4 · Cited by 2,040
Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues
Lai, S. K., Wang, Y.-Y., & Hanes, J. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.11.002 · Cited by 1,815
Treatment of Murine Colitis by Lactococcus lactis Secreting Interleukin-10
Steidler, L., Hans, W., Schotte, L., Neirynck, S., Obermeier, F., Falk, W., Fiers, W., & Remaut, E. (2000) · Science · doi:10.1126/science.289.5483.1352 · Cited by 1,513
Cone, R. A. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.09.008 · Cited by 1,459
Paul Ehrlich's magic bullet concept: 100 years of progress
Strebhardt, K., & Ullrich, A. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2394 · Cited by 1,457
Physical approaches to biomaterial design
Mitragotri, S., & Lahann, J. (2009) · Nature Materials · doi:10.1038/nmat2344 · Cited by 1,445
Guidelines for the management of inflammatory bowel disease in adults
Mowat, C., Cole, A., Windsor, A., Ahmad, T., Arnott, I., Driscoll, R., Mitton, S., Orchard, T., Rutter, M., Younge, L., et al. (2011) · Gut · doi:10.1136/gut.2010.224154 · Cited by 1,419
Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs
Neslihan Gursoy, R., & Benita, S. (2004) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2004.02.001 · Cited by 1,358
Mucosal flora in inflammatory bowel disease
Swidsinski, A., Ladhoff, A., Pernthaler, A., Swidsinski, S., Loening–Baucke, V., Ortner, M., Weber, J., Hoffmann, U., Schreiber, S., Dietel, M., et al. (2002) · Gastroenterology · doi:10.1053/gast.2002.30294 · Cited by 1,346
Biodegradable nanoparticles for drug delivery and targeting
Hans, M. L., & Lowman, A. M. (2002) · Current Opinion in Solid State and Materials Science · doi:10.1016/s1359-0286(02)00117-1 · Cited by 1,324
Bio-inspired, bioengineered and biomimetic drug delivery carriers
Yoo, J.-W., Irvine, D. J., Discher, D. E., & Mitragotri, S. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3499 · Cited by 1,236
The basics and underlying mechanisms of mucoadhesion
SMART, J. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.07.001 · Cited by 1,167
van Furth, R., Cohn, Z. A., Jg, H., Humphrey, J., Spector, W. G., & Langevoort, H. L. (1972) · PubMed Central · Cited by 1,133
Guidelines for the management of inflammatory bowel disease in adults
Carter, M. J., Lobo, A. J., & Travis, S. P. L. (2004) · Gut · doi:10.1136/gut.2004.043372 · Cited by 1,083
Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus
Lai, S. K., O'Hanlon, D. E., Harrold, S., Man, S. T., Wang, Y.-Y., Cone, R., & Hanes, J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608611104 · Cited by 1,050
In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers
Lehr, C.-M., Bouwstra, J. A., Schacht, E. H., & Junginger, H. E. (1992) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(92)90353-4 · Cited by 1,035
Polysaccharide hydrogels for modified release formulations
Coviello, T., Matricardi, P., Marianecci, C., & Alhaique, F. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.01.004 · Cited by 996
Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system
Sengupta, S., Eavarone, D., Capila, I., Zhao, G., Watson, N., Kiziltepe, T., & Sasisekharan, R. (2005) · Nature · doi:10.1038/nature03794 · Cited by 945
Polysaccharides in colon-specific drug delivery
Sinha, V. R., & Kumria, R. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00720-7 · Cited by 872
Mucosal healing in inflammatory bowel diseases: a systematic review
Neurath, M. F., & Travis, S. P. L. (2012) · Gut · doi:10.1136/gutjnl-2012-302830 · Cited by 810
A Phase I Trial With Transgenic Bacteria Expressing Interleukin-10 in Crohn’s Disease
Braat, H., Rottiers, P., Hommes, D. W., Huyghebaert, N., Remaut, E., Remon, J., van Deventer, S. J. H., Neirynck, S., Peppelenbosch, M. P., & Steidler, L. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.03.028 · Cited by 786
Wilson, D. S., Dalmasso, G., Wang, L., Sitaraman, S. V., Merlin, D., & Murthy, N. (2010) · Nature Materials · doi:10.1038/nmat2859 · Cited by 747
Side Effects of Corticosteroid Therapy
Buchman, A. L. (2001) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200110000-00006 · Cited by 745
The origins and evolution of “controlled” drug delivery systems
Hoffman, A. S. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.08.012 · Cited by 738
Role of cytokines in inflammatory bowel disease
Sanchez-Muñoz, F., Dominguez-Lopez, A., & Yamamoto-Furusho, J. K. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.4280 · Cited by 699
Pan, Y., Li, Y.-J., Zhao, H.-Y., Zheng, J.-M., Xu, H., Wei, G., Hao, J.-S., & Cui, F.-D. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00486-6 · Cited by 686
Intestinal barrier dysfunction in inflammatory bowel diseases
McGuckin, M. A., Eri, R., Simms, L. A., Florin, T. H. J., & Radford-Smith, G. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20539 · Cited by 627
Schmitz*, H., Barmeyer*, C., Fromm‡, M., Runkel§, N., Foss∥, H.-D., Bentzel¶, C. J., Riecken*, E.-O., & Schulzke*, J.-D. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70126-5 · Cited by 607
Pulsatile drug release control using hydrogels
Kikuchi, A., & Okano, T. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00243-5 · Cited by 600
Wang, Y., Lai, S. K., Suk, J. S., Pace, A., Cone, R., & Hanes, J. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200803526 · Cited by 597
Jung, T. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(00)00084-9 · Cited by 588
A Cellular Trojan Horse for Delivery of Therapeutic Nanoparticles into Tumors
Choi, M.-R., Stanton-Maxey, K. J., Stanley, J. K., Levin, C. S., Bardhan, R., Akin, D., Badve, S., Sturgis, J., Robinson, J. P., Bashir, R., et al. (2007) · Nano Letters · doi:10.1021/nl072209h · Cited by 584
Colon-specific drug delivery: new approaches and in vitro/in vivo evaluation
Yang, L., Chu, J. S., & Fix, J. A. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00004-2 · Cited by 562
Steidler, L., Neirynck, S., Huyghebaert, N., Snoeck, V., Vermeire, A., Goddeeris, B., Cox, E., Remon, J. P., & Remaut, E. (2003) · Nature Biotechnology · doi:10.1038/nbt840 · Cited by 542
Nanoparticles—a historical perspective
KREUTER, J. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.10.021 · Cited by 540
Bioadhesive microspheres as a controlled drug delivery system
Vasir, J. K., Tambwekar, K., & Garg, S. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00087-5 · Cited by 524
Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis
Wang, Y., Parker, C. E., Bhanji, T., Feagan, B. G., & MacDonald, J. K. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000543.pub4 · Cited by 494
Mucoadhesive nanoparticulate systems for peptide drug delivery
Takeuchi, H., Yamamoto, H., & Kawashima, Y. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00120-4 · Cited by 488
Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis
Wang, Y., Parker, C. E., Feagan, B. G., & MacDonald, J. K. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000544.pub4 · Cited by 483
Biodegradable polymer nanoparticles that rapidly penetrate the human mucus barrier
Tang, B. C., Dawson, M., Lai, S. K., Wang, Y.-Y., Suk, J. S., Yang, M., Zeitlin, P., Boyle, M. P., Fu, J., & Hanes, J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905998106 · Cited by 453
Detection of Vascular Adhesion Molecule-1 Expression Using a Novel Multimodal Nanoparticle
Kelly, K. A., Allport, J. R., Tsourkas, A., Shinde-Patil, V. R., Josephson, L., & Weissleder, R. (2005) · Circulation Research · doi:10.1161/01.res.0000155722.17881.dd · Cited by 449
Grangette, C., Nutten, S., Palumbo, E., Morath, S., Hermann, C., Dewulf, J., Pot, B., Hartung, T., Hols, P., & Mercenier, A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504084102 · Cited by 443
Chitosan nanoparticles for oral drug and gene delivery
Bowman, K., & Leong, K. W. (2006) · International Journal of Nanomedicine · doi:10.2147/nano.2006.1.2.117 · Cited by 439
Mucoadhesive nanoparticulate systems for peptide drug delivery.
Takéuchi, Hirofumi, Yamamoto, Y., Hiromitsu, Kawashima, & Yoshiaki (2002) · 岐阜藥科大學紀要 = The annual proceedings of Gifu College of Pharmacy · Cited by 432
Cationic liposomes target angiogenic endothelial cells in tumors and chronic inflammation in mice.
Thurston, G., McLean, J. W., Rizen, M., Baluk, P., Haskell, A., Murphy, T. J., Hanahan, D., & McDonald, D. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci965 · Cited by 423
Inflammatory bowel disease: the role of environmental factors
Danese, S., Sans, M., & Fiocchi, C. (2004) · Autoimmunity Reviews · doi:10.1016/j.autrev.2004.03.002 · Cited by 406
Biodegradable Nanoparticles for Targeted Drug Delivery in Treatment of Inflammatory Bowel Disease
Lamprecht, A., Ubrich, N., Yamamoto, H., Schäfer, U., Takeuchi, H., Maincent, P., Kawashima, Y., & Lehr, C.-M. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29290-9 · Cited by 403
Behrens, I., Pena, A. I. V., Alonso, M. J., & Kissel, T. (2002) · Pharmaceutical Research · doi:10.1023/a:1019854327540 · Cited by 372
Tobı́o, M., Sánchez, A., Vila, A., Soriano, I., Evora, C., Vila-Jato, J. L., & Alonso, M. J. (2000) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/s0927-7765(99)00157-5 · Cited by 368
Comparative study of the intestinal mucus barrier in normal and inflamed colon
Swidsinski, A., Loening-Baucke, V., Theissig, F., Engelhardt, H., Bengmark, S., Koch, S., Lochs, H., & Dorffel, Y. (2007) · Gut · doi:10.1136/gut.2006.098160 · Cited by 365
Ulbrich, H., Eriksson, E. E., & Lindbom, L. (2003) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2003.10.004 · Cited by 354
Mucosal and Invading Bacteria in Patients with Inflammatory Bowel Disease Compared with Controls
Kleessen, B., Kroesen, A. J., Buhr, H. J., & Blaut, M. (2002) · Scandinavian Journal of Gastroenterology · doi:10.1080/003655202320378220 · Cited by 351
Polysaccharides for Colon Targeted Drug Delivery
Chourasia, M. K., & Jain, S. K. (2004) · Drug Delivery · doi:10.1080/10717540490280778 · Cited by 349
Bacteria-mediated delivery of nanoparticles and cargo into cells
Akin, D., Sturgis, J., Ragheb, K., Sherman, D., Burkholder, K., Robinson, J. P., Bhunia, A. K., Mohammed, S., & Bashir, R. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.149 · Cited by 347
Azoreductase activity of anaerobic bacteria isolated from human intestinal microflora
Rafii, F., Franklin, W., & Cerniglia, C. E. (1990) · Applied and Environmental Microbiology · doi:10.1128/aem.56.7.2146-2151.1990 · Cited by 340
Microemulsions as carriers for drugs and nutraceuticals
Spernath, A., & Aserin, A. (2006) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2006.11.016 · Cited by 325
Lectin-mediated drug delivery:
Lehr, C.-M. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00228-x · Cited by 308
Formulation aspects in the development of osmotically controlled oral drug delivery systems
Verma, R. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00550-8 · Cited by 302
Polysaccharide breakdown by mixed populations of human faecal bacteria
Englyst, H. (1987) · FEMS Microbiology Letters · doi:10.1016/0378-1097(87)90013-9 · Cited by 300
The Key Role of Macrophages in the Immunopathogenesis of Inflammatory Bowel Disease
Mahida, Y. R. (2000) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200002000-00004 · Cited by 293
Orally administered L. lactis secreting an anti-TNF Nanobody demonstrate efficacy in chronic colitis
Vandenbroucke, K., de Haard, H., Beirnaert, E., Dreier, T., Lauwereys, M., Huyck, L., Van Huysse, J., Demetter, P., Steidler, L., Remaut, E., et al. (2010) · Mucosal Immunology · doi:10.1038/mi.2009.116 · Cited by 289
The epidemiology and the pathogenesis of inflammatory bowel disease
Karlinger, K., Györke, T., Makö, E., Mester, Á., & Tarján, Z. (2000) · European Journal of Radiology · doi:10.1016/s0720-048x(00)00238-2 · Cited by 288
Effect of Diet and Lactobacillus acidophilus Supplements on Human Fecal Bacterial Enzymes23
Goldin, B. R., Swenson, L., Dwyer, J., Sexton, M., & Gorbach, S. L. (1980) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/64.2.255 · Cited by 286
Vandenbroucke, K., Hans, W., Van Huysse, J., Neirynck, S., Demetter, P., Remaut, E., Rottiers, P., & Steidler, L. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.05.020 · Cited by 277
Klotz, U. (1985) · Clinical Pharmacokinetics · doi:10.2165/00003088-198510040-00001 · Cited by 277
Cohen, R. D., Woseth, D. M., Thisted, R. A., & Hanauer, S. B. (2000) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2000.01940.x · Cited by 277
Cu, Y., & Saltzman, W. M. (2009) · Molecular Pharmaceutics · doi:10.1021/mp8001254 · Cited by 267
Principles of adoptive T cell cancer therapy
June, C. H. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31446 · Cited by 261
Nano- and microparticulate drug carriers for targeting of the inflamed intestinal mucosa
Collnot, E.-M., Ali, H., & Lehr, C.-M. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.01.028 · Cited by 254
Woodley, J. M. (2001) · Clinical Pharmacokinetics · doi:10.2165/00003088-200140020-00001 · Cited by 253
Vila, A., Gill, H., McCallion, O., & Alonso, M. J. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.04.026 · Cited by 249
The lectin–cell interaction and its implications to intestinal lectin-mediated drug delivery
Gabor, F., Bogner, E., Weissenboeck, A., & Wirth, M. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.015 · Cited by 247
Exploiting M cells for drug and vaccine delivery
Clark, M. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00149-1 · Cited by 246
Sulfasalazine: Pharmacology, Clinical Use, Toxicity, and Related New Drug Development
PEPPERCORN, M. A. (1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-101-3-377 · Cited by 241
Schmidt, C., Lautenschlaeger, C., Collnot, E.-M., Schumann, M., Bojarski, C., Schulzke, J.-D., Lehr, C.-M., & Stallmach, A. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.10.019 · Cited by 237
Self-citationDou, H., Grotepas, C. B., McMillan, J. M., Destache, C. J., Chaubal, M., Werling, J., Kipp, J., Rabinow, B., & Gendelman, H. E. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900274 · Cited by 237
Lectin-mediated mucosal delivery of drugs and microparticles
Clark, M. A., Hirst, B. H., & Jepson, M. A. (2000) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00070-3 · Cited by 236
Review article: infliximab therapy for inflammatory bowel disease – seven years on
RUTGEERTS, P., VAN ASSCHE, G., & VERMEIRE, S. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.02786.x · Cited by 227
Drug diffusion front movement is important in drug release control from swellable matrix tablets
Colombo, P., Bettini, R., Massimo, G., Catellani, P. L., Santi, P., & Peppas, N. A. (1995) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600840816 · Cited by 222
New Concepts in the Pathophysiology of Inflammatory Bowel Disease
Bamias, G., Nyce, M. R., De La Rue, S. A., & Cominelli, F. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-143-12-200512200-00007 · Cited by 221
Oral Controlled Release Formulation Design and Drug Delivery: Theory to Practice
(2010) · Wiley eBooks · doi:10.1002/9780470640487 · Cited by 214
An estimate of turnover time of intestinal mucus gel layer in the rat in situ loop
Lehr, C.-M., Poelma, F. G. J., Junginger, H. E., & Tukker, J. J. (1991) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(91)90287-x · Cited by 212
Extraintestinal manifestations of inflammatory bowel disease
Ardizzone, S., Puttini, P. S., Cassinotti, A., & Porro, G. B. (2008) · Digestive and Liver Disease · doi:10.1016/s1590-8658(08)60534-4 · Cited by 212
Carbohydrate polymers: Applications and recent advances in delivering drugs to the colon
Shukla, R. K., & Tiwari, A. (2012) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2011.12.021 · Cited by 209
Prolonged circulation of large polymeric nanoparticles by non-covalent adsorption on erythrocytes
Chambers, E., & Mitragotri, S. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.08.005 · Cited by 206
The macrophage – a novel system to deliver gene therapy to pathological hypoxia
Griffiths, L., Binley, K., Iqball, S., Kan, O., Maxwell, P., Ratcliffe, P., Lewis, C., Harris, A., Kingsman, S., & Naylor, S. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301058 · Cited by 206
Intravenous Hemostat: Nanotechnology to Halt Bleeding
Bertram, J. P., Williams, C. A., Robinson, R., Segal, S. S., Flynn, N. T., & Lavik, E. B. (2009) · Science Translational Medicine · doi:10.1126/scitranslmed.3000397 · Cited by 203
Osmotically Controlled Oral Drug Delivery*
Verma, R. K., Mishra, B., & Garg, S. (2000) · Drug Development and Industrial Pharmacy · doi:10.1081/ddc-100101287 · Cited by 196
Xiao, B., Laroui, H., Ayyadurai, S., Viennois, E., Charania, M. A., Zhang, Y., & Merlin, D. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.06.008 · Cited by 195
Rodrı́guez, M., Vila-Jato, J. L., & Torres, D. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(98)00029-7 · Cited by 192
Makhlof, A., Tozuka, Y., & Takeuchi, H. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.12.013 · Cited by 192
Green, J. R. B., Lobo, A. J., Holdsworth, C. D., Leicester, R. J., Gibson, J. A., Kerr, G. D., Hodgson, H. J. F., Parkins, K. J., & Taylor, M. D. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70627-4 · Cited by 191
Macrophage Delivery of Therapeutic Nanozymes in A Murine Model of Parkinson‘S Disease
Brynskikh, A. M., Zhao, Y., Mosley, R. L., Li, S., Boska, M. D., Klyachko, N. L., Kabanov, A. V., Gendelman, H. E., & Batrakova, E. V. (2010) · Nanomedicine · doi:10.2217/nnm.10.7 · Cited by 190
Lamprecht, A., Yamamoto, H., Takeuchi, H., & Kawashima, Y. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.088146 · Cited by 187
Short‐term adverse effects of 5‐aminosalicylic acid agents in the treatment of ulcerative colitis
Loftus, E. V., Kane, S. V., & Bjorkman, D. (2004) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.0269-2813.2004.01827.x · Cited by 184
Pharmacokinetics of Budesonide (Entocort??? EC) Capsules for Crohn???s Disease
Edsb??cker, S., & Andersson, T. (2004) · Clinical Pharmacokinetics · doi:10.2165/00003088-200443120-00003 · Cited by 181
Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis
Feagan, B. G., & MacDonald, J. K. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000543.pub3 · Cited by 177
Kriegel, C., & Amiji, M. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.10.002 · Cited by 176
Friend, D. R., & Chang, G. W. (1984) · Journal of Medicinal Chemistry · doi:10.1021/jm00369a005 · Cited by 172
Jani, P. U., McCarthy, D. E., & Florence, A. T. (1992) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(92)90202-d · Cited by 172
SIMONOSKACRCAREVSKA, M. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2007.06.007 · Cited by 166
Transferrin as a Luminal Target for Negatively Charged Liposomes in the Inflamed Colonic Mucosa
Tirosh, B., Khatib, N., Barenholz, Y., Nissan, A., & Rubinstein, A. (2009) · Molecular Pharmaceutics · doi:10.1021/mp9000926 · Cited by 166
Colon-specific delivery of 5-aminosalicylic acid from chitosan-Ca-alginate microparticles
Mladenovska, K., Raicki, R. S., Janevik, E. I., Ristoski, T., Pavlova, M. J., Kavrakovski, Z., Dodov, M. G., & Goracinova, K. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.05.028 · Cited by 166
Mucosal bacterial microflora and mucus layer thickness inadolescents with inflammatory bowel disease
Fyderek, K., Strus, M., Kowalska‐Duplaga, K., Gosiewski, T., Wędrychowicz, A., Jedynak‐Wąsowicz, U., Sładek, M., Pieczarkowski, S., Adamski, P., Kochan, P., et al. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.5287 · Cited by 166
Polymers in Drug Delivery—State of the Art and Future Trends
Grund, S., Bauer, M., & Fischer, D. (2011) · Advanced Engineering Materials · doi:10.1002/adem.201080088 · Cited by 165
Self-citationDifferential adhesion of normal and inflamed rat colonic mucosa by charged liposomes
Jubeh, T. T., Barenholz, Y., & Rubinstein, A. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000019298.29561.cd · Cited by 164
Quality of life of patients with ulcerative colitis: Past, present, and future
Irvine, J. E. (2007) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20301 · Cited by 164
Papadakis, K. A., Shaye, O. A., Vasiliauskas, E. A., Ippoliti, A., Dubinsky, M. C., Loane, J., Paavola, J., Lee, S. K., Price, J., Targan, S. R., et al. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.40647.x · Cited by 161
Targeting nanoparticles to M cells with non-peptidic ligands for oral vaccination
Fievez, V., Plapied, L., des Rieux, A., Pourcelle, V., Freichels, H., Wascotte, V., Vanderhaeghen, M.-L., Jerôme, C., Vanderplasschen, A., Marchand-Brynaert, J., et al. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2009.04.009 · Cited by 158
Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis
Feagan, B. G., & MacDonald, J. K. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000544.pub3 · Cited by 158
Laroui, H., Theiss, A. L., Yan, Y., Dalmasso, G., Nguyen, H. T. T., Sitaraman, S. V., & Merlin, D. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.09.062 · Cited by 157
Rochat, T., Bermúdez‐Humarán, L. G., Gratadoux, J., Fourage, C., Hoebler, C., Corthier, G., & Langella, P. (2007) · Microbial Cell Factories · doi:10.1186/1475-2859-6-22 · Cited by 154
Pozzi, F., Furlani, P., Gazzaniga, A., Davis, S. S., & Wilding, I. R. (1994) · Journal of Controlled Release · doi:10.1016/0168-3659(94)90255-0 · Cited by 148
Topical delivery of therapeutic agents in the treatment of inflammatory bowel disease
Klotz, U. E., & Schwab, M. G. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.08.007 · Cited by 147
Yano, H. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00532-6 · Cited by 146
Foligné, B., Dessein, R., Marceau, M., Poiret, S., Chamaillard, M., Pot, B., Simonet, M., & Daniel, C. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.06.018 · Cited by 145
Watterlot, L., Rochat, T., Sokol, H., Cherbuy, C., Bouloufa, I., Lefèvre, F., Gratadoux, J., Honvo‐Houeto, E., Chilmonczyk, S., Blugeon, S., et al. (2010) · International Journal of Food Microbiology · doi:10.1016/j.ijfoodmicro.2010.03.037 · Cited by 143
Claudin 4-targeted protein incorporated into PLGA nanoparticles can mediate M cell targeted delivery
Rajapaksa, T. E., Stover-Hamer, M., Fernandez, X., Eckelhoefer, H. A., & Lo, D. D. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.10.033 · Cited by 137
Health-related quality of life in Crohn's disease: a prospective longitudinal study in 231 patients.
Blondel-Kucharski, F., Chircop, C., Marquis, P., Cortot, A., Baron, F., Jp, G., & Colombel, J. (2001) · PubMed · doi:10.1111/j.1572-0241.2001.4681_b.x · Cited by 134
M cell targeting by lectins: a strategy for mucosal vaccination and drug delivery
Jepson, M. A., Clark, M. A., & Hirst, B. H. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.018 · Cited by 130
Rizzello, F., Gionchetti, P., D’Arienzo, A., Manguso, F., Matteo, G. D., Annese, V., Valpiani, D., Casetti, T., Adamo, S., Prada, A., et al. (2002) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2002.01298.x · Cited by 130
5-amino salicylic acid bound nanoparticles for the therapy of inflammatory bowel disease
Pertuit, D., Moulari, B., Betz, T., Nadaradjane, A., Neumann, D., Ismaïli, L., Refouvelet, B., Pellequer, Y., & Lamprecht, A. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.08.008 · Cited by 129
Han, W., Mercenier, A., Ait-Belgnaoui, A., Pavan, S., Lamine, F., van Swam, I. I., Kleerebezem, M., Salvador–Cartier, C., Hisbergues, M., Bueno, L. P., et al. (2006) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000235101.09231.9e · Cited by 126
Microbial host interactions in IBD: Implications for pathogenesis and therapy
Sartor, R. B., & Muehlbauer, M. (2007) · Current Gastroenterology Reports · doi:10.1007/s11894-007-0066-4 · Cited by 123
Bioadhesion by Means of Specific Binding of Tomato Lectin
Lehr, C., Bouwstra, J. A., Kok, W., Noach, A. B. J., de Boer, A. G., & Junginger, H. E. (1992) · Pharmaceutical Research · doi:10.1023/a:1015804816582 · Cited by 122
Muraoka, M., Hu, Z., Shimokawa, T., Sekino, S.-I., Kurogoshi, R.-E., Kuboi, Y., Yoshikawa, Y., & Takada, K. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00201-0 · Cited by 121
Health-related quality of life in Crohn’s disease: a prospective longitudinal study in 231 patients
Blondel-Kucharski, F., Chircop, C., Marquis, P., Cortot, A., Baron, F., Gendre, J.-P., Colombel, J.-F., & (GETAID), T. G. D. T. D. A. I. D. (2001) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2001.04681.x · Cited by 120
Mayr, U. B., Haller, C., Haidinger, W., Atrasheuskaya, A. V., Bukin, E., Lubitz, W., & Ignatyev, G. M. (2005) · Infection and Immunity · doi:10.1128/iai.73.8.4810-4817.2005 · Cited by 120
Archampong, E. Q., Harris, J., & Clark, C. G. (1972) · Gut · doi:10.1136/gut.13.11.880 · Cited by 119
Anti-TNF therapy in inflammatory bowel diseases: a huge review.
Peyrin‐Biroulet, L. (2010) · PubMed · Cited by 118
A pH-sensitive microsphere system for the colon delivery of tacrolimus containing nanoparticles
Lamprecht, A., Yamamoto, H., Takeuchi, H., & Kawashimà, Y. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.02.011 · Cited by 118
Osmotically Controlled Drug Delivery System with Associated Drugs
Gupta, B. P., Thakur, N., Jain, N. P., Banweer, J., & Jain, S. (2010) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/j38w25 · Cited by 116
Lectin-mediated transport of nanoparticles across Caco-2 and OK cells
Russell-Jones, G. J., Veitch, H. S., & Arthur, L. M. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00254-9 · Cited by 116
Tahara, K., Samura, S., Tsuji, K., Yamamoto, H., Tsukada, Y., Bando, Y., Tsujimoto, H., Morishita, R., & Kawashimà, Y. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.09.034 · Cited by 115
Türkoğlu, M., & Uğurlu, T. (2002) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(01)00225-9 · Cited by 112
Squishy Non‐Spherical Hydrogel Microparticles
Haghgooie, R., Toner, M., & Doyle, P. S. (2009) · Macromolecular Rapid Communications · doi:10.1002/marc.200900302 · Cited by 111
Wadworth, A. N., & Fitton, A. (1991) · Drugs · doi:10.2165/00003495-199141040-00009 · Cited by 110
Yin, Y.-S., Chen, D., Qiao, M., Wei, X., & Hu, H. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.06.024 · Cited by 109
Paukner, S., Köhl, G., & Lubitz, W. (2003) · Journal of Controlled Release · doi:10.1016/j.jconrel.2003.09.010 · Cited by 109
Ohama, T., Hori, M., & Ozaki, H. (2007) · Journal of Smooth Muscle Research · doi:10.1540/jsmr.43.43 · Cited by 103
Nakase, H., Okazaki, K., Tabata, Y., Uose, S., Ohana, M., Uchida, K., Matsushima, Y., Kawanami, C., Oshima, C., Ikada, Y., et al. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35256-5 · Cited by 101
Feagan, B. G., Chande, N., & MacDonald, J. K. (2013) · Inflammatory Bowel Diseases · doi:10.1097/mib.0b013e3182920108 · Cited by 94
Quantification of the bioadhesive properties of protein-coated PVM/MA nanoparticles
Arbós, P., Arangoa, M. A., Campanero, M. A., & Irache, J. M. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00182-5 · Cited by 93
Jubeh, T. T., Nadler-Milbauer, M., Barenholz, Y., & Rubinstein, A. (2006) · Journal of drug targeting · doi:10.1080/10611860600648429 · Cited by 89
Optimization of conventional therapy in patients with IBD
Taylor, K. M., & Irving, P. M. (2011) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2011.172 · Cited by 88
Ireland, A., Mason, C., & Jewell, D. P. (1988) · Gut · doi:10.1136/gut.29.6.835 · Cited by 87
State of the Art: Ibd Therapy and Clinical Trials in Ibd
Isaacs, K. L., Lewis, J. D., Sandborn, W. J., Sands, B. E., & Targan, S. R. (2005) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000184852.84558.b2 · Cited by 85
Human erythrocytes as nanoparticle carriers for magnetic particle imaging
Markov, D. E., Boeve, H., Gleich, B., Borgert, J., Antonelli, A., Sfara, C., & Magnani, M. (2010) · Physics in Medicine and Biology · doi:10.1088/0031-9155/55/21/008 · Cited by 85
Activation, stimulation and uptake of bacterial ghosts in antigen presenting cells
Haslberger, A. G., Köhl, G., Felnerova, D., et al. (2000) · Journal of Biotechnology · doi:10.1016/s0168-1656(00)00298-4 · Cited by 82
D’Argenio, G., Calvani, M., Casamassimi, A., Petillo, O., Margarucci, S., Rienzo, M., Peluso, I., Calvani, R., Ciccodicola, A., Caporaso, N., et al. (2006) · The FASEB Journal · doi:10.1096/fj.06-5950fje · Cited by 81
Annese, V., Latiano, A., Rossi, L., et al. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.41412.x · Cited by 80
In Vitro Characterization of Human Intact Erythrocytes Loaded by Enalaprilat
Hamidi, M., Tajerzadeh, H., Dehpour, A. R., Rouini, M. R., & Ejtemaee-Mehr, S. (2001) · Drug Delivery · doi:10.1080/107175401317245903 · Cited by 79
In Vitro Evaluation of Dexamethasone-β-D-Glucuronide for Colon-Specific Drug Delivery
Haeberlin, B., Rubas, W., Nolen, H. W., & Friend, D. R. (1993) · Pharmaceutical Research · doi:10.1023/a:1018956232628 · Cited by 77
Kriegel, C., & Amiji, M. M. (2011) · Clinical and Translational Gastroenterology · doi:10.1038/ctg.2011.1 · Cited by 75
In-vitroandIn-vivoEvaluation of Mesalazine–Guar Gum Matrix Tablets for Colonic Drug Delivery
Tuğcu-Demiröz, F., Acartürk, F., Takka, S., & Konuş-Boyunağa, Ö. (2004) · Journal of drug targeting · doi:10.1080/10611860410001693751 · Cited by 75
Nanocompartments Enclosing Vesicles, Colloids, and Macromolecules via Interdigitated Lipid Bilayers
Kisak, E., Coldren, B. A., & Zasadzinski, J. A. (2001) · Langmuir · doi:10.1021/la0156053 · Cited by 74
Management of extraintestinal manifestations and other complications of inflammatory bowel disease
Loftus, E. V. (2004) · Current Gastroenterology Reports · doi:10.1007/s11894-004-0073-7 · Cited by 72
Bossa, F., Latiano, A., Rossi, L., Magnani, M., Palmieri, O., Dallapiccola, B., Serafini, S., Damonte, G., Santo, E. D., Andriulli, A., et al. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.02103.x · Cited by 70
Structural specializations for antigen uptake and processing in the digestive tract
Owen, R., & Ermak, T. H. (1990) · Springer Seminars in Immunopathology · doi:10.1007/bf00197502 · Cited by 69
Mura, C., Nácher, A., Merino, V., Merino‐Sanjuán, M., Cardá, C., Ruiz-Garcı́a, A., Manconi, M., Loy, G., Fadda, A. M., & Dı́ez-Sales, O. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.06.025 · Cited by 69
Steed, K. P., Hooper, G., Monti, N. C., Benedetti, M. S., Fornasini, G., & Wilding, I. R. (1997) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00062-x · Cited by 69
DNA-Loaded Bacterial Ghosts Efficiently Mediate Reporter Gene Transfer and Expression in Macrophages
Paukner, S., Kudela, P., Köhl, G., Schlapp, T., Friedrichs, S., & Lubitz, W. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2004.09.024 · Cited by 68
Studies on lactulose formulations for colon-specific drug delivery
Katsuma, M., Watanabe, S., Kawai, H., Takemura, S., Masuda, Y., & Fukui, M. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00429-5 · Cited by 66
Ertl, B., Heigl, F., Wirth, M., & Gabor, F. (2000) · Journal of drug targeting · doi:10.3109/10611860008996863 · Cited by 64
Engineered E. coli delivers therapeutic genes to the colonic mucosa
Castagliuolo, I., Beggiao, E., Brun, P., Barzon, L., Goussard, S., Manganelli, R., Grillot‐Courvalin, C., & Palù, G. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302493 · Cited by 62
Topical Treatment of Distal Active Ulcerative Colitis With Beclomethasone Dipropionate or Mesalamine
Gionchetti, P., D’Arienzo, A., Rizzello, F., Manguso, F., Maieron, R., Lecis, P., Valpiani, D., Iaquinto, G., Annese, V., Balzano, A., et al. (2005) · Journal of Clinical Gastroenterology · doi:10.1097/01.mcg.0000155124.74548.61 · Cited by 61
Tuleu, C., Basit, A. W., Waddington, W. A., Ell, P. J., & Newton, J. (2002) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2002.01327.x · Cited by 56
Intestinal Mucus Barrier in Normal and Inflamed Colon
Corazziari, E. S. (2009) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e3181a117ea · Cited by 55
Jung, Y. J., Lee, J. S., & Kim, Y. M. (2000) · Journal of Pharmaceutical Sciences · Cited by 52
Kudela, P., Paukner, S., Mayr, U. B., Cholujová, D., Schwarczova, Z., Sedlák, J., Bízik, J., & Lubitz, W. (2005) · Journal of Immunotherapy · doi:10.1097/01.cji.0000154246.89630.6f · Cited by 52
Badhana, S., Garud, N., & Garud, A. (2013) · International Current Pharmaceutical Journal · doi:10.3329/icpj.v2i3.13577 · Cited by 50
Gibson, P. G., Fixa, B., Pekárková, B., Bátovský, M., Radford‐Smith, G. L., TIBITANZL, J., Gabalec, L., Florin, T. H., & Greinwald, R. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.02861.x · Cited by 49
Studies of chitosan/organic acid/Eudragit® RS/RL-coated system for colonic delivery
Kaur, K., & Kim, K. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.09.006 · Cited by 47
Covalent coupling of asparagus pea and tomato lectins to poly(lactide) microspheres
Montisci, M., Giovannuci, G., Duchêne, D., & Ponchel, G. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(00)00678-5 · Cited by 46
Enhanced adhesion of ligand‐conjugated biodegradable particles to colitic venules
Sakhalkar, H. S., Hanes, J. S., Fu, J., Benavides, U., Malgor, R., Borruso, C. L., Kohn, L. D., Kurjiaka, D. T., & Goetz, D. J. (2005) · The FASEB Journal · doi:10.1096/fj.04-2668fje · Cited by 45
Kruis, W., Judmaier, G., Kayasseh, L., Stolte, M., Theuer, D., Scheurlen, C., Hentschel, E., & Kratochvíl, P. (1995) · PubMed · Cited by 44
Bacterial ghosts as carrier and targeting systems
Lubitz, W. (2001) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.1.5.765 · Cited by 44
Leopold, C. S., & Eikeler, D. (1998) · Journal of drug targeting · doi:10.3109/10611869808997884 · Cited by 43
Lipids-based drug carrier systems by dense gas technology: A review
Beh, C. C., Mammucari, R., & Foster, N. R. (2012) · Chemical Engineering Journal · doi:10.1016/j.cej.2012.01.129 · Cited by 41
Fraternale, A., Casabianca, A., Orlandi, C., Cerasi, A., Chiarantini, L., Brandi, G., & Magnani, M. (2002) · Antiviral Research · doi:10.1016/s0166-3542(02)00128-6 · Cited by 41
Montisci, M., Dembri, A., Giovannuci, G., et al. (2001) · Pharmaceutical Research · doi:10.1023/a:1011044730790 · Cited by 40
Jung, Y. J., Lee, J. S., Kim, H. H., Kim, Y. T., & Kim, Y. M. (1998) · Archives of Pharmacal Research · doi:10.1007/bf02974025 · Cited by 37
Kesisoglou, F., Zhou, S. Y., Niemiec, S. M., Lee, J. W., Zimmermann, E. M., & Fleisher, D. (2005) · Pharmaceutical Research · doi:10.1007/s11095-005-5376-3 · Cited by 37
Ricci, S., Macchia, G., Ruggiero, P., Maggi, T., Bossù, P., Xu, L., Medaglini, D., Tagliabue, A., Hammarström, L. L. G., Pozzi, G., et al. (2003) · BMC Biotechnology · doi:10.1186/1472-6750-3-15 · Cited by 33
FK506 Microparticles Mitigate Experimental Colitis with Minor Renal Calcineurin Suppression
Lamprecht, A., Yamamoto, H., Ubrich, N., Takeuchi, H., Maincent, P., & Kawashimà, Y. (2005) · Pharmaceutical Research · doi:10.1007/s11095-004-1186-2 · Cited by 33
Zou, M. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i47.7457 · Cited by 32
Ocampo, S. M., Romero, C., Aviñó, A. M., Burgueño, J. F., Gassull, M. A., Bermúdez, J., Eritja, R., Fernández, E., & Perales, J. C. (2011) · Molecular Therapy · doi:10.1038/mt.2011.236 · Cited by 30
Crcarevska, M. S., Dodov, M. G., Petruševska, G., Gjorgoski, I., & Goračinova, K. (2009) · Journal of drug targeting · doi:10.3109/10611860903161310 · Cited by 28
The Pharmacological Profile and Clinical Use of Mesalazine (5-Aminosalicylic Acid)
Klotz, U. E. (2012) · Arzneimittelforschung · doi:10.1055/s-0031-1299685 · Cited by 28
Baker, D. E., & Kane, S. V. (2004) · PubMed · Cited by 28
Biodegradable Nanoparticles for Targeted Delivery in Treatment of Ulcerative Colitis
Mahajan, N. M., Sakarkar, D. M., Manmode, A. S., Pathak, V., Ingole, R. S., & Dewade, D. R. (2011) · Advanced Science Letters · doi:10.1166/asl.2011.1247 · Cited by 27
Salmonella-mediated gene therapy in experimental colitis in mice
Pálffy, R., Gardlík, R., Behuliak, M., Jani, P., Balakova, D., Kádaši, Ľ., Turňa, J., & Celec, P. (2011) · Experimental Biology and Medicine · doi:10.1258/ebm.2010.010277 · Cited by 26
Functions of the human mononuclear phagocyte system (a condensed review)
Becker, S. (1988) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(88)90003-8 · Cited by 23
Colonic delivery of carboxyfluorescein by pH-sensitive microspheres in experimental colitis
Kietzmann, D., Moulari, B., Béduneau, A., Pellequer, Y., & Lamprecht, A. (2010) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2010.06.013 · Cited by 21
Cited by
Lee, Y., Sugihara, K., Gillilland, M. G., Jon, S., Kamada, N., & Moon, J. J. (2020) · Nature Materials · doi:10.1038/s41563-019-0462-9 · Cited by 707
Formulation, stabilisation and encapsulation of bacteriophage for phage therapy
Malik, D. J., Sokolov, I. J., Vinner, G. K., Mancuso, F., Cinquerrui, S., Vladisavljevic, G. T., Clokie, M. R. J., Garton, N. J., Stapley, A. G. F., & Kirpichnikova, A. (2017) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2017.05.014 · Cited by 594
Cao, F., Jin, L., Gao, Y., Ding, Y., Wen, H., Qian, Z., Zhang, C., Hong, L., Yang, H., Zhang, J., et al. (2023) · Nature Nanotechnology · doi:10.1038/s41565-023-01346-x · Cited by 472
Alginate microparticles as oral colon drug delivery device: A review
Agüero, L., Zaldivar-Silva, D., Peña, L., & Dias, M. L. (2017) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2017.03.033 · Cited by 460
Kumar Singh, A., Cabral, C., Kumar, R., Ganguly, R., Kumar Rana, H., Gupta, A., Rosaria Lauro, M., Carbone, C., Reis, F., & Pandey, A. K. (2019) · Nutrients · doi:10.3390/nu11092216 · Cited by 433
Metadata
- Authors
- Lautenschläger, C., Schmidt, C., Fischer, D., & Stallmach, A.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2014-05
- Volume
- 71
- Pages
- 58-76
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W2094956472
- Cited by
- 291
- References
- 206
- FWCI
- 1.62
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.